This article is more than 5 years old. Information may no longer be current.

Integra LifeSciences names new CEO, CFO for SeaSpine

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Integra LifeSciences Holdings Corp. recently announced the appointment of Keith Valentine as CEO of SeaSpine Holdings Corp. SeaSpine will become an independent, publicly traded company following the completion of its spin-off from Integra, according to a company release.

Additionally, John Bostjancic has been appointed as chief financial officer (CFO) for SeaSpine, according to the release.

SeaSpine, a global medical technology company, focuses on surgical solutions for the treatment of spinal disorders. Located in Vista, Calif., SeaSpine has a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions.

Prior to joining SeaSpine, Valentine served as president and chief operating officer of NuVasive from January 2007 to January 2015.

Bostjancic has been acting CFO of SeaSpine since December 2014. He was most recently a senior vice president of Global Supply Chain at Integra from February 2012 to November 2014. From 2008 to January 2012, Bostjancic was senior vice president of financial planning and analysis, according to the release.

SeaSpine is expected to complete its spinoff from Integra LifeSciences in the second half of 2015, the release stated.

Reference: www.integralife.com.